Choroidal sclerosis is a rare eye condition that affects the layer of blood vessels under the retina. People with choroidal sclerosis may notice blurry vision, blind spots, or trouble seeing in dim light. It can be long-lasting and may slowly worsen, and not everyone will have the same experience. Many people with choroidal sclerosis are diagnosed in adulthood, and vision changes can vary by age and subtype. Treatment focuses on protecting vision with regular eye exams, treating complications like inflammation or fluid buildup, and using low-vision aids when needed, and the condition is not life-threatening.
Overview
Choroidal sclerosisSymptoms
Choroidal sclerosis can be silent at first. People may notice blurry or dim vision, trouble seeing at night, distorted or patchy spots in the visual field, and eye discomfort or light sensitivity. Symptoms vary by location and severity.
Outlook and prognosis
Most people with choroidal sclerosis notice vision changes that progress slowly, often over years. Regular eye exams, protection from bright light, and timely treatment for complications can help preserve useful sight. Your individual outlook depends on the pattern, both eyes involved, and other eye conditions.
Causes and risk factors
Choroidal sclerosis usually reflects damage or scarring in the choroid from aging, chronic inflammation, or prior infection. Risk factors for choroidal sclerosis include autoimmune disease, past uveitis, high myopia, vascular problems, and ocular trauma. Rarely, inherited susceptibility contributes.
Genetic influences
Genetics may play a role in choroidal sclerosis, but clear inherited patterns are uncommon. Some people have rare gene changes that affect the retina–choroid complex and raise risk. A detailed family history and, when appropriate, genetic testing can help guide care.
Diagnosis
Diagnosis of choroidal sclerosis relies on eye exam findings—central retinal thinning and atrophy—supported by imaging such as OCT and autofluorescence. Visual tests may assess central vision loss. Genetic tests can confirm inheritance; this supports the genetic diagnosis of choroidal sclerosis.
Treatment and drugs
Treatment for choroidal sclerosis focuses on protecting vision, easing inflammation, and watching for complications. Eye doctors may use prescription anti‑inflammatory drops or injections, manage related conditions, adjust glasses or contact lenses, and recommend low‑vision aids when needed. Regular eye exams guide these choices over time.
Symptoms
Vision changes from choroidal sclerosis often show up in everyday tasks. Symptoms vary from person to person and can change over time. People sometimes notice dim lighting feels harder, print looks less crisp, or a small patch of vision seems missing; these can be early symptoms of choroidal sclerosis.
Words and faces look less sharp, especially in low light or when you’re tired. Glasses may not fully clear the blur if the back layer of the eye is affected.
Dim rooms, dusk, or nighttime driving feel much darker than before. You may need extra light to move around or read signs.
A dark or gray patch can appear when you look straight at something. This can make small print, threading a needle, or recognizing faces harder.
The edges of what you see may fade or feel narrowed. Some people with choroidal sclerosis bump into door frames or miss steps on the side.
How people usually first notice Choroidal sclerosis?
Many people first notice choroidal sclerosis when vision changes creep in one eye, such as blurry or dim spots, trouble seeing in low light, or colors looking washed out. An eye doctor may be the first to suspect it during a routine dilated exam or imaging, seeing patches where the blood-rich layer behind the retina (the choroid) looks thinned or scarred. If symptoms are subtle, it’s often the scan—like optical coherence tomography (OCT) or fluorescein angiography—that reveals the first signs of choroidal sclerosis before everyday vision problems become obvious.
Types of Choroidal sclerosis
Choroidal sclerosis affects the layer of blood vessels under the retina and can show up in different ways depending on cause and pattern. Clinicians often describe them in these categories: inflammatory-related forms, hereditary or primary degenerations, and patterns tied to aging or other eye conditions. Symptoms don’t always look the same for everyone. Some people notice blurry or dim patches in their vision, while others have trouble seeing in low light or notice straight lines bending.
Inflammatory variant
Vision changes follow or accompany eye inflammation. People may have episodes of blurry spots, light sensitivity, or floaters when inflammation is active. Scarring in the choroid and retina can leave lasting blind spots.
Primary degenerative
Gradual thinning and scarring occur without obvious inflammation. Night vision problems and difficulty with peripheral vision can build slowly over years. Some notice trouble reading in dim rooms before central vision is affected.
Hereditary pattern
Runs in families and may start earlier in life. Symptoms can include progressive blind spots, reduced contrast, and slow dark adaptation. The course and severity can vary widely across relatives.
Age-related pattern
Often appears alongside age-related retinal changes. People may notice wavy lines, central blur, or faded colors when choroidal support to the retina declines. Risk rises with other age-linked eye conditions.
Secondary to other disease
Linked to systemic conditions like autoimmune disease or prior infections. Vision may fluctuate as the underlying condition flares or improves. Treating the root cause can stabilize some symptoms.
Localized scarring
Small, well-defined patches of choroidal scarring cause focal blind spots. Reading lines may have tiny gaps or missing letters where the spot sits. Early symptoms of choroidal sclerosis in this type can be subtle and easy to miss.
Diffuse involvement
Widespread choroidal thinning leads to broader visual field loss. People may struggle with low-light tasks and glare sensitivity. For many, certain types stand out more than others.
Unilateral versus bilateral
Some have changes in one eye, others in both. One eye may lag or lead the other in symptom onset and severity. Having one type doesn’t necessarily mean you’ll develop the others.
What genetics can tell you about symptoms
Certain variants in the TIMP3 gene can cause choroidal sclerosis, leading to reduced night vision, blind spots, and gradual central vision loss as the layer that supports the retina thickens and scars. Some people also develop distorted vision and trouble recognizing faces.
Causes and risk factors
Choroidal sclerosis often develops after years of strain on the eye’s blood supply from aging or high blood pressure. Past eye inflammation, infections, or injury can leave scars in the choroid and set the stage for this change. Some risks are modifiable (things you can change) and others are non-modifiable (things you can’t). Family history of retinal or choroidal disease can raise susceptibility, and smoking or poor control of diabetes adds to the burden. Common risk factors for choroidal sclerosis include older age, uncontrolled high blood pressure, diabetes, high cholesterol, smoking, hardening of the arteries, and a history of eye inflammation or trauma.
Environmental and biological risk factors
Day-to-day, problems in the blood-rich layer behind the retina can make reading in dim light harder or cause blurry patches that come and go. This scarring and stiffening is called choroidal sclerosis. Doctors often group risks into internal (biological) and external (environmental). Below are key environmental and biological risk factors for choroidal sclerosis to discuss with your eye specialist.
Age-related thinning and stiffening of the choroid can raise the chance of choroidal sclerosis. Over time, the small vessels that feed the retina grow less flexible and deliver less blood.
Conditions that reduce blood flow, such as long-standing high blood pressure or artery narrowing, can strain the choroid. Less perfusion makes this layer more vulnerable to scarring.
Eye or body-wide inflammatory disorders can inflame the choroid and trigger scarring. Repeated flares may stiffen this tissue over time.
Past infections in the back of the eye can leave patches of scar tissue. These scars can contribute to choroidal sclerosis and reduce oxygen supply to nearby retina.
Genetic risk factors
Many people first hear about choroidal sclerosis during a routine eye check, sometimes after dim night vision or small blank spots off to the side. In many, it reflects changes from other eye conditions that can run in families. Some risk factors are inherited through our genes. Because early symptoms of choroidal sclerosis can be subtle, understanding the genetic possibilities can guide whether relatives might need an exam or whether genetic testing could clarify risk.
Family history: Having close relatives with inherited retinal or choroidal conditions suggests a higher genetic contribution to your findings. This can make choroidal sclerosis more likely to appear within a family across generations.
X-linked disorders: Conditions such as choroideremia or some X-linked retinitis pigmentosa can thin and scar the choroid. In these families, males are usually more affected, and carriers may show subtle choroidal sclerosis on exam.
Dominant retinal dystrophies: Gene changes in PRPH2 or TIMP3 can cause progressive choroidal and retinal damage that may be labeled as choroidal sclerosis. Each child of an affected parent has a 50% chance to inherit the change.
Recessive metabolic disease: Rare enzyme-related eye disorders, such as gyrate atrophy from OAT gene changes, can injure the choroid over time. The condition appears when both gene copies are altered, so risk is highest if both parents carry the same variant.
Elastic tissue disorders: Pseudoxanthoma elasticum (ABCC6) affects the layer under the retina and can lead to angioid streaks and choroidal damage. Family members may share the gene change but have different eye findings or timing.
Variable gene effects: The same inherited change can look very different between relatives, from minor scarring to more obvious choroidal sclerosis. Age and other genes can modify severity and the age at which changes are noticed.
Population variants: In some communities, specific gene changes are more common due to founder effects, increasing the chance of inherited choroidal disorders. This can make choroidal sclerosis–like findings more frequent in those groups.
Lifestyle risk factors
Certain daily habits can influence blood vessel health in the eye, which can affect choroidal sclerosis over time. Below is a focused look at lifestyle risk factors for Choroidal sclerosis and how modifying them may help protect choroidal circulation. Diet, activity, and cardiometabolic control are central to how lifestyle affects Choroidal sclerosis.
Tobacco accelerates damage to the choroidal microvasculature and can hasten sclerosis. Quitting can improve endothelial function and may slow progression of choroidal scarring.
Chronic hypertension stiffens and narrows choroidal vessels, worsening perfusion. Blood-pressure–lowering habits like reduced sodium and regular exercise may limit further choroidal damage.
Elevated glucose harms small vessels in the choroid similar to diabetic retinopathy. Keeping A1c in target can reduce microvascular injury and may slow ischemic changes in the choroid.
Diets high in saturated fats and ultra-processed foods promote atherosclerosis that can involve choroidal vessels. A Mediterranean-style pattern rich in produce, whole grains, and omega-3s may support choroidal blood flow.
Risk prevention
Choroidal sclerosis involves changes in the blood-rich layer at the back of the eye, so protecting circulation and eye health can help lower risk and slow progression. Prevention is about lowering risk, not eliminating it completely. For most people, the biggest gains come from regular eye care and controlling heart and metabolic risks. It also helps to notice early symptoms of choroidal sclerosis—like trouble seeing in dim light or new patchy blind spots—so you can get checked promptly.
Yearly dilated exams help spot early choroidal sclerosis changes before vision is affected. Screenings and check-ups are part of prevention too.
High blood pressure can stiffen and narrow the eye’s tiny vessels and speed choroidal sclerosis changes. Aim for steady, well-managed readings with medication and lifestyle steps as advised.
Diabetes harms small blood vessels that nourish the choroid. Keeping A1C and daily sugars in target ranges may slow choroidal sclerosis–related damage.
Smoking reduces blood flow and increases oxidative stress in the eye. Stopping can lower the chance of choroidal sclerosis getting worse over time.
Transmission
Choroidal sclerosis is not infectious—you can’t catch it from someone or pass it through everyday contact, sex, blood, or the air.
When choroidal sclerosis runs in families, it is usually inherited in an autosomal dominant way, meaning one altered copy of a gene is enough to cause the condition. If a parent lives with choroidal sclerosis, each child has a 50% chance to inherit the gene change; sometimes it appears for the first time due to a new mutation. A genetics professional can explain how choroidal sclerosis is inherited and the genetic transmission of choroidal sclerosis, including whether relatives might benefit from testing.
When to test your genes
Choroidal sclerosis is rare, so genetic testing is usually considered only if there’s a strong family history of similar eye disease, early vision changes without a clear cause, or a known hereditary retinal disorder in relatives. Testing can confirm the cause and guide monitoring and treatment. Ask an eye genetics specialist first.
Diagnosis
Changes in the choroid (the blood-rich layer under the retina) can affect how you see in dim light, cause blurred spots, or make straight lines look wavy. For many, the first step comes when everyday activities start feeling harder, such as driving at dusk or reading fine print. Tests may feel repetitive, but each one helps rule out different causes. Doctors usually begin with a detailed eye exam and then add imaging and functional tests to build a clear picture of what’s happening and confirm the diagnosis of Choroidal sclerosis.
Your eye doctor asks about vision changes, light sensitivity, glare, and any blind spots. Timing, triggers, and whether one or both eyes are affected help narrow the cause.
A review of past eye conditions, high myopia, autoimmune disease, infections, and medications can point to risks. Family history and general health details add useful context.
Drops widen the pupil so the retina and choroid can be examined closely. The doctor looks for pale or thinned areas, pigment changes, or scarring that fit with choroidal sclerosis.
OCT takes cross‑section pictures of the retina and choroid. It shows thinning, scarring, or fluid that might explain vision loss.
Stages of Choroidal sclerosis
Choroidal sclerosis does not have defined progression stages. The term often describes scarring or thinning in the layer beneath the retina from different causes, so it’s followed by what shows up on exam and any changes in vision rather than a formal stage system; early symptoms of choroidal sclerosis may be mild or go unnoticed. An eye specialist usually checks with a dilated eye exam and imaging such as optical coherence tomography (OCT), retinal photos, or dye studies if needed. Different tests may be suggested to help clarify the cause and guide follow‑up.
Outlook and prognosis
Looking at the long-term picture can be helpful. For many people with choroidal sclerosis, vision changes tend to unfold slowly over years, not weeks. You might notice dim environments getting harder to navigate or reading taking more light and time. The outlook is not the same for everyone, but some people keep useful central vision for many years, while others have a more noticeable decline that affects driving, night vision, or fine detail work.
Prognosis refers to how a condition tends to change or stabilize over time. Choroidal sclerosis mainly affects sight, not life expectancy, so mortality is not increased by the eye condition itself. Early symptoms of choroidal sclerosis, such as trouble with low-light settings or patchy blind spots, can plateau for a while and then progress, often in a stepwise pattern. Regular eye exams, protective measures like UV-blocking lenses, and treating any related inflammation or blood vessel changes can help slow further damage and prolong functional vision.
Everyone’s journey looks a little different. If genetic factors or associated conditions are involved, progression may vary more, and your eye specialist may tailor follow-up and treatments accordingly. With ongoing care, many people maintain independence in daily tasks using brighter lighting, magnifiers, and vision-rehab strategies, and some continue to work and drive depending on local rules and individual vision testing. Talk with your doctor about what your personal outlook might look like.
Long-term effects
Choroidal sclerosis affects the thin blood-rich layer at the back of the eye and can lead to scarring that changes how clearly you see. Long-term effects vary widely, from mild blurring to more noticeable blind spots. Some people notice changes build slowly over years, while others experience periods when vision shifts more quickly. Doctors often describe these as long-term effects or chronic outcomes.
Sharpness for reading and fine detail may slowly decline. You might find small print harder to make out over time. The pace can differ greatly from person to person.
Patchy blind spots can develop to the side of what you are looking at. This can make navigating crowded spaces or crossing streets more challenging. You may notice missing areas when doing visual field tests.
Dim lighting may feel especially difficult, with slower adjustment from bright to dark. Driving at dusk or walking in poorly lit areas can become harder. These can be early symptoms of choroidal sclerosis.
Bright light may feel harsh or uncomfortable. Headlights, sunlight, or glossy surfaces can create halos or wash out detail. Moving between lighting conditions can briefly reduce clarity.
How is it to live with Choroidal sclerosis?
Living with choroidal sclerosis can feel unpredictable at first, especially if vision changes come on slowly and differ between eyes. Many notice trouble with dim lighting, glare, or reading fine print, and some experience blank or blurry spots that make tasks like driving, schoolwork, or detailed jobs harder; good lighting, high‑contrast materials, and magnification often help. Regular eye exams, low‑vision rehabilitation, and practical tools—screen readers, large‑print settings, tinted lenses—can preserve independence, while planning rest breaks can reduce eye strain. Family, friends, and coworkers may need simple adjustments—better room lighting, clear printouts, patience with pace—but with these supports, most people build reliable routines and stay engaged in the activities that matter.
Treatment and drugs
Treatment for choroidal sclerosis focuses on protecting vision, easing symptoms like glare or blurry spots, and managing any related inflammation or complications. There’s no single cure, so care often includes regular eye exams, prescription lenses or low‑vision aids, and sun protection to reduce light sensitivity. If inflammation or swelling is present, doctors may use targeted medicines such as corticosteroid eye drops, injections around the eye, or immunosuppressive drugs; in selected cases, anti-VEGF injections can help if abnormal vessel growth or leakage develops. Treatment plans often combine several approaches, and may also include managing blood pressure, cholesterol, and other vascular risks to support eye health. Ask your doctor about the best starting point for you.
Non-drug treatment
Changes in vision can affect reading, driving, and getting around, so practical supports matter day to day for people living with Choroidal sclerosis. Alongside medicines, non-drug therapies can make tasks safer, reduce eye strain, and help you use the vision you have more comfortably. If you’re noticing early symptoms of Choroidal sclerosis, small adjustments to lighting, contrast, and how you set up your space can go a long way. These approaches are tailored to your goals and can be updated as your vision needs change.
Specialized therapists teach ways to read, navigate, and manage glare using your remaining vision. They also match you with tools that fit your daily routines.
Brighter, well-placed lights and high-contrast labels make details easier to see. Task lamps and matte surfaces can cut glare and eye fatigue.
Indoor or outdoor tints and clip-on filters can reduce light sensitivity and improve contrast. Your optometrist can help test colors to find what’s most comfortable.
Handheld magnifiers, stand magnifiers, and electronic video magnifiers enlarge text and images. Many people like apps or e-readers that allow adjustable zoom and contrast.
Your genes may have an impact on how drugs work for you
Genes can affect how people with choroidal sclerosis process certain medicines, changing how quickly a drug is broken down or how strongly it works. Pharmacogenetic testing, when available, may help clinicians choose safer doses and avoid side effects.
Pharmacological treatments
Choroidal sclerosis can’t be reversed with medicine, but drugs can treat complications like swelling, inflammation, or new leaky blood vessels that threaten sight. Early symptoms of choroidal sclerosis may be mild, so treatment usually starts when active changes are seen on eye exam or imaging. Choices depend on the exact problem and whether there’s inflammation or abnormal vessel growth. Not everyone responds to the same medication in the same way.
Ranibizumab, aflibercept, bevacizumab, or faricimab can shrink abnormal blood vessels and reduce leakage. They’re given as small injections into the eye at intervals your ophthalmologist sets. Vision and eye pressure are monitored closely at each visit.
Prednisone by mouth or steroid injections/implants (triamcinolone acetonide, dexamethasone implant) can calm inflammation and reduce swelling. These are used when there’s active inflammatory activity affecting the retina or choroid. Side effects can include higher eye pressure, cataract risk, or changes in blood sugar.
Methotrexate, mycophenolate mofetil, azathioprine, or biologics like adalimumab may be used if an autoimmune or uveitis component is driving disease activity. They help control ongoing inflammation to protect vision. Regular blood tests and check-ins help track safety.
Acetazolamide by mouth or eye drops like dorzolamide or brinzolamide can lessen macular edema (fluid in the retina). Reducing fluid can sharpen central vision in selected cases. Common effects include tingling, altered taste, or mild fatigue with oral forms.
Genetic influences
Many people ask whether choroidal sclerosis is hereditary; in some families, it is. In certain forms—especially those that center on the macula (the sharp-vision area)—one changed copy of a gene from either parent can be enough to cause the condition, which means each child has about a 1 in 2 (50%) chance of inheriting it. Family history is one of the strongest clues to a genetic influence. Researchers have linked some families to changes in genes that help the retina and choroid keep their structure, such as PRPH2, though not every case has a known gene yet. Even within the same family, the age symptoms start and how quickly vision changes can differ a lot. Genetic testing and counseling for choroidal sclerosis may confirm a cause, guide screening of relatives, and support planning, but a positive result doesn’t always predict exactly how your vision will unfold.
Is Choroidal sclerosis genetic?
Genetics may play a role in choroidal sclerosis, but clear inherited patterns are uncommon. Some people have rare gene changes that affect the retina–choroid complex and raise risk. A detailed family history and, when appropriate, genetic testing can help guide care.
Pharmacogenetics—how genetics influence drug effects
Treatment for choroidal sclerosis may include steroid eye drops or tablets, immune‑modulating medicines, and sometimes injections to block new, leaky blood vessels in the eye. Genetic testing can sometimes identify how your body processes certain medicines, helping tailor dosing and lower the chance of serious side effects. If a thiopurine such as azathioprine is being considered to calm inflammation, checking for enzyme differences (often called TPMT or NUDT15) can guide a safer starting dose and monitoring plan. For tacrolimus or cyclosporine, inherited differences in liver enzymes may mean you need a higher or lower dose; doctors often pair this information with blood‑level checks. With steroids, some people are “steroid responders” who develop a marked rise in eye pressure; genetics likely contributes, but there isn’t a validated test yet to predict this in routine care. For anti‑VEGF injections used if abnormal vessels form, studies of gene markers are ongoing, but they aren’t used to choose a specific drug for choroidal sclerosis at this time. In practice, pharmacogenetics and choroidal sclerosis treatment come together alongside your eye exam, imaging, and overall health to shape a plan that aims for benefit with the fewest risks.
Interactions with other conditions
Many living with choroidal sclerosis also have other eye or general health conditions, and the mix can shape how vision changes over time. Doctors call it a “comorbidity” when two conditions occur together. Macular degeneration, high myopia (nearsightedness), or past eye inflammation (uveitis) can add strain to the same layers at the back of the eye, so choroidal sclerosis may lead to more noticeable glare, trouble in dim light, or slower recovery after flare‑ups. Diabetes and high blood pressure can affect the eye’s circulation; when choroidal sclerosis is present, these issues may increase the chance of vision swings or make healing from small leaks or bleeds take longer. Autoimmune disease and infections that inflame the back of the eye can also interact with early symptoms of choroidal sclerosis, sometimes speeding scar formation and making blind spots or distortion more obvious. Because treatments for one problem can influence another—such as steroids affecting eye pressure or blood thinners changing bleeding risk—plans are often tailored to balance safety and vision needs across all conditions.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described sudden changes in central vision—letters fading on a page, colors looking washed out, or a dark smudge that won’t go away. Families and communities once noticed patterns when several relatives developed similar vision trouble in midlife, often starting in one eye and then the other. These everyday stories helped clinicians look more closely at the back of the eye and document what they were seeing.
First described in the medical literature as patchy thinning of the layer that nourishes the retina, choroidal sclerosis was initially recognized by looking through the pupil with early ophthalmoscopes in the 19th and early 20th centuries. Early reports used a variety of names, reflecting what doctors could observe at the time: pale areas where blood flow seemed reduced, islands of retinal damage, and edges where healthy tissue met scarred tissue. Not every early description was complete, yet together they built the foundation of today’s knowledge.
As medical science evolved, photographs of the retina made it possible to track changes over years, not just during a single visit. Fluorescein angiography in the mid-20th century highlighted the choroid’s blood supply in real time, showing where vessels were lost or leaking. Later, optical coherence tomography (OCT) provided cross-sectional “slices” of the retina and choroid, revealing how thinning and scarring progressed layer by layer. These tools turned scattered observations into clearer patterns that linked symptoms—blurry or distorted central vision—with visible changes in the eye.
From early theories to modern research, the story of choroidal sclerosis has broadened from isolated case reports to carefully defined clinical entities. Doctors learned to separate choroidal sclerosis from look-alike conditions such as age-related macular degeneration, inflammatory chorioretinal disorders, and inherited dystrophies. In recent decades, knowledge has built on a long tradition of observation. Improved imaging, wider patient registries, and standardized terms helped clarify who is most affected, which features predict faster change, and how often both eyes become involved.
Advances in genetics added another layer. While many people with choroidal sclerosis do not have a single known gene change, studies of families with similar patterns pointed to pathways involved in the health of the choroid and retina. This work explained why some individuals develop early symptoms of choroidal sclerosis in their 30s or 40s, while others notice changes much later.
Looking back helps explain current care. What began as careful drawings and brief case notes has grown into detailed maps of the back of the eye, clearer definitions, and earlier recognition. This history shapes today’s approach: confirm the diagnosis with imaging, rule out related disorders, and follow changes over time so treatment and low-vision support can be offered when they’re most helpful.